Preclinical Vaccine Development: Implementing the Food and Drug Administration's Good Laboratory Practices in a Biocontainment Environment-A University BSL3/BSL4 Laboratory Perspective

Melissa M. Eitzen, Andrew G. McNees, David Beasley

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish (US)
Title of host publicationVaccines for Biodefense and Emerging and Neglected Diseases
PublisherElsevier Inc.
Pages131-146
Number of pages16
ISBN (Print)9780123694089
DOIs
StatePublished - 2009

Fingerprint

United States Food and Drug Administration
Vaccines

ASJC Scopus subject areas

  • Immunology and Microbiology(all)

Cite this

Preclinical Vaccine Development : Implementing the Food and Drug Administration's Good Laboratory Practices in a Biocontainment Environment-A University BSL3/BSL4 Laboratory Perspective. / Eitzen, Melissa M.; McNees, Andrew G.; Beasley, David.

Vaccines for Biodefense and Emerging and Neglected Diseases. Elsevier Inc., 2009. p. 131-146.

Research output: Chapter in Book/Report/Conference proceedingChapter

Eitzen, Melissa M. ; McNees, Andrew G. ; Beasley, David. / Preclinical Vaccine Development : Implementing the Food and Drug Administration's Good Laboratory Practices in a Biocontainment Environment-A University BSL3/BSL4 Laboratory Perspective. Vaccines for Biodefense and Emerging and Neglected Diseases. Elsevier Inc., 2009. pp. 131-146
@inbook{28a8cd0cda864538b3bac4994d8c9c16,
title = "Preclinical Vaccine Development: Implementing the Food and Drug Administration's Good Laboratory Practices in a Biocontainment Environment-A University BSL3/BSL4 Laboratory Perspective",
author = "Eitzen, {Melissa M.} and McNees, {Andrew G.} and David Beasley",
year = "2009",
doi = "10.1016/B978-0-12-369408-9.00010-X",
language = "English (US)",
isbn = "9780123694089",
pages = "131--146",
booktitle = "Vaccines for Biodefense and Emerging and Neglected Diseases",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Preclinical Vaccine Development

T2 - Implementing the Food and Drug Administration's Good Laboratory Practices in a Biocontainment Environment-A University BSL3/BSL4 Laboratory Perspective

AU - Eitzen, Melissa M.

AU - McNees, Andrew G.

AU - Beasley, David

PY - 2009

Y1 - 2009

UR - http://www.scopus.com/inward/record.url?scp=84884447811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884447811&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-369408-9.00010-X

DO - 10.1016/B978-0-12-369408-9.00010-X

M3 - Chapter

AN - SCOPUS:84884447811

SN - 9780123694089

SP - 131

EP - 146

BT - Vaccines for Biodefense and Emerging and Neglected Diseases

PB - Elsevier Inc.

ER -